Oral medication for skin allergy is a key part of managing conditions such as urticaria, atopic eczema, allergic contact dermatitis, and angioedema, particularly when topical treatments alone are insufficient. In the UK, options range from over-the-counter antihistamines such as cetirizine and loratadine to prescription-only treatments including oral corticosteroids and immunosuppressants. Choosing the right medication depends on the underlying diagnosis, symptom severity, and individual patient factors. This guide covers how these medicines work, how to access them through the NHS, important safety considerations, and when to seek further medical advice.

Common Oral Medications Used to Treat Skin Allergies in the UK

Skin allergies encompass a range of conditions — including urticaria (hives), atopic eczema, allergic contact dermatitis, and angioedema — and oral medications play a central role in managing symptoms when topical treatments alone are insufficient. In the UK, the most widely used oral medications for skin allergies fall into several categories:

• Antihistamines (e.g., cetirizine, loratadine, fexofenadine, chlorphenamine)

• Oral corticosteroids (e.g., prednisolone) for short-term use in severe flares

• Immunosuppressants (e.g., ciclosporin, methotrexate, azathioprine) for chronic or refractory conditions

Second-generation antihistamines such as cetirizine and loratadine are typically the first-line choice for urticaria and are available over the counter at pharmacies without a prescription. They are generally preferred over first-generation antihistamines (such as chlorphenamine) due to their more favourable side-effect profile and longer duration of action. It is important to note that antihistamines have a limited role in managing atopic eczema — they do not treat the underlying skin inflammation, and sedating antihistamines are only occasionally used to help with sleep disruption during flares.

For allergic contact dermatitis, the mainstay of management is identifying and avoiding the causative allergen alongside topical corticosteroids; short courses of oral corticosteroids are reserved for severe or widespread reactions. Angioedema may be histamine-mediated (responding to antihistamines and corticosteroids) or bradykinin-mediated — for example, when triggered by ACE inhibitor medicines — in which case antihistamines and steroids are ineffective and urgent medical assessment is required.

For more complex or persistent skin allergies, a GP or dermatologist may consider stepping up treatment. Oral corticosteroids are occasionally prescribed for short courses during acute flares. Ciclosporin is licensed for severe atopic dermatitis; methotrexate and azathioprine are used off-label for refractory inflammatory skin conditions and require specialist initiation and regular monitoring. Some patients with severe atopic eczema or chronic spontaneous urticaria may be considered for injectable biologic therapies (such as dupilumab or omalizumab) — these are not oral medicines and are initiated and monitored exclusively within specialist settings under NICE technology appraisal criteria (NICE TA534; NICE TA339).

The choice of oral medication for a skin allergy depends on the underlying diagnosis, symptom severity, and individual patient factors.

How Antihistamines and Other Oral Medicines Help Relieve Allergic Skin Reactions

Understanding how oral medications work can help patients use them more effectively and set realistic expectations about symptom relief.

Allergic skin reactions such as urticaria are primarily driven by the release of histamine from mast cells and basophils in response to an allergen. Histamine binds to H1 receptors in the skin, causing the characteristic symptoms of itching, redness, swelling, and whealing. Antihistamines work by competitively blocking H1 receptors, thereby reducing these effects. It is important to note, however, that not all allergic skin conditions are primarily histamine-driven:

• Atopic eczema itch is not mainly mediated by histamine; antihistamines do not treat eczema inflammation. Sedating antihistamines (e.g., chlorphenamine) may occasionally be used short-term to help with sleep disruption during a flare, but are not routine maintenance therapy.

• Allergic contact dermatitis is a T-cell–mediated reaction; antihistamines provide limited benefit and management centres on allergen avoidance and topical corticosteroids.

• Bradykinin-mediated angioedema (e.g., ACE inhibitor–related) does not respond to antihistamines or corticosteroids and requires urgent specialist assessment.

Second-generation antihistamines (cetirizine, loratadine, fexofenadine) are selective for peripheral H1 receptors and have limited penetration of the blood-brain barrier, meaning they cause significantly less sedation than older agents. For chronic spontaneous urticaria (CSU), regular daily dosing is more effective than taking antihistamines only when symptoms arise. For intermittent or mild urticaria, as-needed use may be sufficient — a clinician can advise on the most appropriate approach.

Oral corticosteroids such as prednisolone act more broadly by suppressing the immune response and reducing inflammation across multiple pathways. They are effective for acute, severe allergic reactions but are not suitable for long-term use due to the risk of systemic side effects.

For patients with severe, treatment-resistant conditions, specialist-led injectable biologic therapies may be considered. Dupilumab targets the interleukin-4 and interleukin-13 signalling pathways that drive type 2 inflammation in atopic eczema. Omalizumab binds to immunoglobulin E (IgE) and is licensed for CSU unresponsive to antihistamines. These are subcutaneous injections, not oral medicines, and are only available through specialist services.

Getting a Diagnosis and Prescription Through the NHS

Accessing the right oral medication for a skin allergy through the NHS begins with an accurate diagnosis. Many patients self-manage mild symptoms using over-the-counter antihistamines available from pharmacies, and pharmacists can offer valuable guidance on appropriate product selection. However, if symptoms are persistent, severe, or unclear in origin, a consultation with a GP is the appropriate next step.

During a GP appointment, the clinician will typically:

• Take a detailed history of symptoms, triggers, and duration

• Examine the affected skin

• Consider differential diagnoses (e.g., eczema, psoriasis, contact dermatitis)

• Arrange targeted investigations where clinically indicated

Investigations are guided by the clinical history rather than performed routinely. Patch testing is specifically indicated when allergic contact dermatitis is suspected and is usually arranged via a dermatology department. Skin-prick testing or specific IgE blood tests are appropriate when an IgE-mediated allergy (such as a food or environmental allergen) is suspected from the history. In chronic spontaneous urticaria, routine allergy testing is generally not recommended, as a specific allergen trigger is rarely identified.

NICE CKS guidance on urticaria and atopic eczema supports a structured approach to diagnosis and management, with clear pathways for escalation. If a GP suspects a complex allergy or the condition does not respond to first-line treatment, a referral to a dermatologist or NHS allergy clinic may be arranged. Waiting times can vary, but the NHS e-Referral Service facilitates access to specialist care.

Some prescription-only medications — including oral corticosteroids and immunosuppressants — require a formal diagnosis and ongoing clinical monitoring. Patients should not attempt to obtain or use prescription medications without appropriate medical supervision, as incorrect use can mask serious conditions or cause harm. If a clinician recommends a higher antihistamine dose for CSU (up to four times the standard dose), this is an off-label use and should only be undertaken on explicit clinician advice — patients should not increase their own dose without guidance.

Dosage Guidance, Side Effects, and Safety Considerations

Dosage of oral medication for skin allergy varies depending on the specific drug, the patient's age, weight, renal function, and the severity of the condition. Always follow the prescriber's instructions or the patient information leaflet supplied with the medication. Do not exceed the stated dose unless specifically advised to do so by a clinician.

Common dosage examples (adults):

• Cetirizine: 10 mg once daily

• Loratadine: 10 mg once daily

• Fexofenadine: 120–180 mg once daily (depending on indication)

• Prednisolone: variable short courses, typically 20–40 mg daily, tapering as directed by the prescriber

Side effects to be aware of include:

• Second-generation antihistamines: generally well tolerated; mild headache, dry mouth, or gastrointestinal upset may occur; sedation is uncommon but possible

• First-generation antihistamines (e.g., chlorphenamine): significant sedation, impaired concentration, urinary retention — do not drive or operate machinery whilst taking these

• Oral corticosteroids: with prolonged or repeated use, risks include weight gain, raised blood glucose, mood changes, osteoporosis, and adrenal suppression; repeated short courses should prompt specialist review

• Ciclosporin: requires regular monitoring of renal function and blood pressure

• Methotrexate: taken once weekly (not daily) with folic acid supplementation; requires regular blood monitoring (full blood count, liver and renal function); it is teratogenic — effective contraception is essential for both men and women during treatment and for a period afterwards

• Azathioprine: requires TPMT enzyme testing before starting and regular full blood count and liver function monitoring

Drug interactions: Patients should inform their prescriber of all other medications they are taking. A clinically relevant example is fexofenadine, whose plasma levels are increased by erythromycin and ketoconazole — your pharmacist or prescriber can advise on specific interactions for your medicines. Alcohol should be avoided when taking sedating antihistamines.

Pregnancy and breastfeeding: If you are pregnant, planning a pregnancy, or breastfeeding, always seek medical advice before taking any antihistamine or other allergy medicine. Based on available safety data, loratadine or cetirizine are generally considered the preferred antihistamine options during pregnancy, but a clinician should be consulted. The BNF and NHS provide specific guidance on medicines in pregnancy and breastfeeding.

Reporting side effects: Suspected adverse reactions to any medicine can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. This helps to monitor the ongoing safety of medicines used in the UK.

When to Seek Further Medical Advice or Specialist Referral

Whilst many skin allergies can be effectively managed with over-the-counter or GP-prescribed oral medication, there are important situations where prompt medical attention or specialist referral is warranted.

Contact your GP if:

• Symptoms persist despite two to four weeks of appropriate antihistamine treatment

• The rash is spreading, worsening, or associated with significant pain

• You experience recurrent episodes without an identifiable trigger

• Symptoms are significantly affecting sleep, work, or quality of life

• You develop side effects from prescribed medication

Seek emergency medical care (call 999 or go to A&E) if you experience:

• Sudden swelling of the lips, tongue, throat, or face (angioedema)

• Difficulty breathing or swallowing

• Dizziness, collapse, or a rapid heartbeat alongside a skin reaction — these may indicate anaphylaxis, a life-threatening emergency requiring immediate treatment

It is also important to be aware that angioedema occurring without urticaria or itch — particularly in patients taking ACE inhibitor medicines — may be bradykinin-mediated rather than histamine-mediated. This type of angioedema does not respond to antihistamines or corticosteroids and requires urgent assessment in an emergency department.

GP referral to a dermatologist or allergy specialist is recommended when the diagnosis is uncertain, when patch testing or formal allergy investigation is required, or when second-line treatments such as immunosuppressants or biologics are being considered. NICE CKS guidance on urticaria and atopic eczema, alongside British Association of Dermatologists (BAD) and BSACI guidelines, outlines clear criteria for specialist referral, helping to ensure patients receive timely and appropriate care.

Patients with a known risk of severe allergic reactions may be prescribed an adrenaline auto-injector (available in the UK under brand names including EpiPen and Jext) and should receive training in its use. Guidance on the emergency management of anaphylaxis is provided by the Resuscitation Council UK.

Managing Skin Allergies Alongside Oral Treatment

Oral medication for skin allergy is most effective when used as part of a broader management strategy. Identifying and avoiding known triggers remains a cornerstone of long-term allergy control and can significantly reduce the frequency and severity of flares.

Practical self-management measures include:

• Using fragrance-free, dye-free emollients regularly to maintain the skin barrier — this is particularly important in atopic eczema and should be continued even when the skin appears clear

• Wearing loose, breathable clothing (preferably cotton) to minimise irritation

• Avoiding known allergens such as certain metals, latex, cosmetic ingredients, or foods where relevant

• For chronic spontaneous urticaria, common aggravating factors such as NSAIDs (e.g., ibuprofen), heat, and physical pressure may worsen symptoms in some individuals — discuss with your GP or specialist

• Keeping a symptom diary to help identify patterns and triggers

• Choosing fragrance-free laundry products and considering an extra rinse cycle if skin sensitivity is a concern; the benefit of non-biological detergents specifically is not well established, so it is worth individualising this based on your own experience

For patients with atopic eczema, topical corticosteroids and calcineurin inhibitors (e.g., tacrolimus) are the mainstay of flare management and are used alongside emollients. Antihistamines do not treat eczema inflammation; sedating antihistamines may occasionally help with sleep disruption during a flare but are not recommended as routine maintenance therapy. The NHS provides structured support through eczema action plans, which help patients and carers understand when to step treatment up or down.

Mental health and wellbeing should not be overlooked. Chronic skin conditions can have a significant psychological impact, contributing to anxiety, low self-esteem, and sleep disturbance. Patients are encouraged to discuss these concerns with their GP, who can signpost to appropriate support services. Organisations such as the British Skin Foundation and Allergy UK also offer reliable patient resources and peer support networks to complement medical treatment.

Frequently Asked Questions